Mutant endoglycoceramidases with enhanced synthetic activity
US-10294504-B2 · May 21, 2019 · US
Vaughan Mark is listed as an inventor on 2 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Vaughan Mark |
| Total patents | 2 |
| First publication | Feb 4, 2016 |
| Latest publication | May 21, 2019 |
Publications ranked by popularity score, then publication date.
US-10294504-B2 · May 21, 2019 · US
US-2016032342-A1 · Feb 4, 2016 · US
Latest publications not already listed above.
No data yet.
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ British Columbia | 2 |
| Seneb Biosciences Inc | 1 |
| La Jolla Pharma Co | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12P19/26 | 2 |
| C12N9/2402 | 2 |
| C12Y302/01123 | 2 |